Pharmacy

Retail pharmacies can now sell abortion pills under new FDA modifications.

CMS concurs with OIG's recommendation and says it will determine whether additional guidance would help ensure more accurate ASP calculations.

Naomi Fried, PharmStars' founder and CEO, discusses the company's spring 2023 cohort, and its call for applications to digital health groups across the world who focus on women's health and health equity for underserved populations.

The drug was estimated to cost Medicare $12B in one year, representing 36% of the 2018 Part B budget.

The XBB variant, which is resistant to immunity, now makes up over half of cases in New England.

The issue is one of demand, not supply, experts say.

Overall, 51% of enrolled patients using Adstiladrin therapy achieved a complete response, with all signs of cancer disappearing.

The companies hope the treatment will provide greater efficacy as the virus evolves and proves increasingly resistant to current therapies.

The company believes the equivalent therapies will lower healthcare costs while providing more choice and flexibility.

The end result will be a "diversified pharmacy solutions organization" serving commercial markets and government programs.